Literature DB >> 10372938

Hemolytic anemia secondary to alpha-interferon treatment in a patient with chronic C hepatitis.

C de-la-Serna-Higuera1, R Bárcena-Marugán, E Sanz-de-Villalobos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10372938     DOI： 10.1097/00004836-199906000-00017

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  5 in total

1.  Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis C.

Authors:  R J Fontana
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

2.  Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient.

Authors:  Ashraf Said; Ashraf Elbahrawy; Mohamed Alfiomy; Mohamed Abdellah; Khaled Shahat; Mohamed Salah; Sadek Mostafa; Ahmed Elwassief; Attef Aboelfotoh; Hafez Abdelhafeez; Assem El-Sherif
Journal:  BMJ Case Rep       Date:  2011-08-11

3.  Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.

Authors:  Elizabeth Y Chiao; Eric A Engels; Jennifer R Kramer; Kenneth Pietz; Louise Henderson; Thomas P Giordano; Ola Landgren
Journal:  Arch Intern Med       Date:  2009-02-23

Review 4.  Immunological alterations in hepatitis C virus infection.

Authors:  Vincenza Calvaruso; Antonio Craxì
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 5.  Hepatitis C virus and autoimmunity.

Authors:  Barbara C Böckle; Norbert T Sepp
Journal:  Auto Immun Highlights       Date:  2010-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.